Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a novel 15‐CpG‐based signature for predicting prognosis in triple‐negative breast cancer

10 Jul 2020

Abstract excerpt

DNA methylation is an important biological regulatory mechanism that changes gene expression without altering the DNA sequence. Increasing studies have revealed that DNA methylation data play a vital role in the field of oncology. However, the methylation site signature in triple-negative breast cancer (TNBC) remains unknown. In our research, we analysed 158 TNBC samples and 98 noncancerous samples from The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32649035
DOI: 10.1111/jcmm.15588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a novel 15‐CpG‐based signature for predicting prognosis in triple‐negative breast cancerPMID 32649035Read ↗

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast CancerSemantic proximity Read ↗

A seven‐DNA methylation signature as a novel prognostic biomarker in breast cancerSemantic proximity Read ↗

DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer PatientsSemantic proximity Read ↗

A seven-gene CpG-island methylation panel predicts breast cancer progressionSemantic proximity Read ↗

Identification of methylation sites and signature genes with prognostic value for luminal breast cancerSemantic proximity Read ↗

A novel epigenetic signature for overall survival prediction in patients with breast cancerSemantic proximity Read ↗

A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast CancerSemantic proximity Read ↗

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinomaSemantic proximity Read ↗

Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinomaSemantic proximity Read ↗

Genome-wide DNA methylation profiling in triple-negative breast cancer reveals epigenetic signatures with important clinical valueSemantic proximity Read ↗

Targeting DNA Methylation for Treating Triple-Negative Breast CancerSemantic proximity Read ↗

Development and validation of a DNA methylation signature to predict the progression-free survival in patients with advanced-stage ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.